Adherence to asthma treatments: 'We know, we intend, we advocate'

Current Opinion in Allergy and Clinical Immunology

Volumn 15, Issue 1, 2015, Pages 49-55

  Braido, Fulvio ^a   Baiardini, Ilaria ^a   Blasi, Francesco ^b   Pawankar, Ruby ^c   Canonica, Giorgio W ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Adherence; asthma; control; cost; manifesto

Indexed keywords

ANTIASTHMATIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID;

ASTHMA; DISEASE CONTROL; DISEASE EXACERBATION; DOCTOR PATIENT RELATION; DRUG COST; DRUG DELIVERY DEVICE; DRUG MONITORING; EOSINOPHIL; FAMILY FUNCTIONING; HEALTH BELIEF; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE UTILIZATION; HEALTH EDUCATION; HEALTH STATUS; HOME ENVIRONMENT; HUMAN; INHALER; LONG TERM CARE; LUNG FUNCTION; MEDICATION COMPLIANCE; MORTALITY; MOTIVATION; PARENTAL ATTITUDE; PATIENT COMPLIANCE; PATIENT COUNSELING; PHARMACY; PRIORITY JOURNAL; REMINDER SYSTEM; REVIEW; SELF CARE; ANIMAL; HEALTH CARE DELIVERY;

ANIMALS; ASTHMA; HEALTH SERVICES ACCESSIBILITY; HUMANS; MEDICATION ADHERENCE; PHYSICIAN-PATIENT RELATIONS;

EID: 84920889435     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0000000000000132     Document Type: Review

References (40)

1. World Health Organization (WHO). Adherence to long-term therapies: evidence for action. 2003. whqlibdoc.who.int/publications/2003/9241545992. pdf.
2. Van Dulmen S, Sluijs E, van Dijk L, et al. Patient adherence to medical treatment: a review of reviews. BMC Health Serv Res 2007; 7:55-68.
3. Sabate E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.
4. Clatworthy J, Price D, Ryan D, et al. The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control. Prim Care Respir J 2009; 18:300-305.
5. Latry P, Pinet M, Labat A, et al. Adherence to anti-inflammatory treatment for asthma in clinical practice in France. Clin Ther 2008; 30 Spec No:1058-1068.
6. Jentzsch NS, Camargos P, Sarinho ES, Bousquet J. Adherence rate to beclomethasone dipropionate and the level of asthma control. Respir Med 2012; 106:338-343.
7. O'Conor R, Wolf MS, Smith SG, et al. Health literacy, cognitive function, proper use and adherence to inhaled asthma controller medications among older adults with asthma. Chest 2014. doi: 10.1378/chest.14-0914.
8. Bårnes CB, Ulrik CS. Asthma and adherence to inhaled corticosteroids: current status and future perspectives. Respir Care 2014; pii: respcare. 03200.
9. Bateman ED. Treatment adherence in asthmatic patients: the last frontier? Allergy Clin Immunol 2014. pii: S0091-6749(14)01116-6.
10. Cutler DM1, Everett W. Thinking outside the pillbox-medication adherence as a priority for healthcare reform. N Engl J Med 2010; 362:1553-1555.
11. Bender BG, Rand C. Medication nonadherence and asthma treatment cost. Chest 2013; 144:428-435.
12. Di Matteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care 2004; 42:200-209.
13. Sadatsafavi M, Fitzgerald M, Marra C, Lynd L. Costs and health outcomes associated with primary vs secondary care after an asthma-related hospita-lization: a population-based study. Chest 2013; 144:428-435.
14. Desai M, Oppenheimer JJ. Medication adherence in the asthmatic child and adolescent. Curr Allergy Asthma Rep 2011; 11:454-464.
15. Drotar D, Bonner MS. Influencesonadherenceto pediatric asthma treatment: a review of correlates and predictors. J Dev Behav Pediatr 2009; 30:574-582.
16. Baiardini I, Braido F, Bonini M, et al. Why do doctors and patients not follow guidelines? Curr Opin Allergy Clin Immunol 2009; 9:228-233.
17. Bender DG. Overcoming barriers to nonadherence in asthma treatment. J Allergy Clin Immunol 2002; 109 (6 Suppl.):S554-S559.
18. Van Steenis M, Driesenaar J, Bensing J, et al. Relationship between medication beliefs, self-reported and refill adherence, and symptomsinpatients with asthma using inhaled corticosteroids. Patient Prefer Adherence 2014; 8:83-91.
19. Braido F, Baiardini I, Sumberesi M, et al. Obstructive lung diseases and inhaler treatment: results from a national public pragmatic survey. Respir Res 2013; 14:94.
20. Sabate E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003. http://www.who.int/chronic- conditions/adherencereport/en/.
21. Morisky DE, Kominski GF, Afifi AA, Kotlerman JB. The effects of a disease management program onself-reported health behaviors and health outcomes: evidence from the 'Florida: a healthy state (FAHS)' Medicaid program. Health Educ Behav 2009; 36:505-517.
22. Armour C, Bosnic-Anticevich S, Brillant M, et al. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax 2007; 62:496-502.
23. Kritikos V, Armour CL, Bosnic-Anticevich SZ. Interactive small-group asthma education in the community pharmacy setting: a pilot study. J Asthma 2007; 44:57-64.
24. Wang KY, Chian CF, Lai HR, et al. Clinical pharmacist counseling improves outcomes for Taiwanese asthma patients. Pharm World Sci 2010; 32:721-729.
25. Gaude GS, Hattiholi J, Chaudhury AJ. Role of health education and self-action plan in improving the drug compliance in bronchial asthma. Family Med Prim Care 2014; 3:33-38.
26. Auger KA, Kahn RS, Davis MM, et al. Pediatric asthma readmission: asthma knowledge is not enough? J Pediatr 2014.
27. Brooks TL, Leventhal H, Wolf MS, et al. Strategies used by older adults with asthma for adherence to inhaled corticosteroids. J Gen Intern Med 2014; 29:1506-1512.
28. Lindner PS, Lindner AJ. Gender differences in asthma inhaler compliance. Conn Med 2014; 78:207-210
29. J Manag Care Pharm 2014; 20:786-792.
30. Berg J, Dunbar J, Rohay J. Compliance with inhaled medications: the relationship between diary and electronic monitoring. Ann Behav Med 1998; 20:36-38.
31. Patel M, Perrin K, Pritchard A, Williams M, et al. Accuracy of patient self-report as a measure of inhaled asthma medication use. Respirology 2013; 18:546-552.
32. Foster JM, Smith L, Usherwood T, et al. The reliability and patient acceptability of the SmartTrack device: a new electronic monitor and reminder device for metered dose inhalers. J Asthma 2012; 49:657-662.
33. Hall RL, Willgoss T, Humphrey L, et al. The effect of medical device dose-memory functions on patients' adherence to treatment, confidence, and disease self-management. Patient Prefer Adherence 2014; 8:775-788.
34. Van Boven JF, Stuurman-Bieze AG, Hiddink EG, et al. Medication monitoring and optimization: a targeted pharmacist program for effective and cost-effective improvement of chronic therapy adherence. J Manag Care Pharm 2014; 20:786-792.
35. Haynes RB, Ackloo E, Sahota N, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008; 2:CD000011.
36. Foster JM, Usherwood T, Smith L, et al. Inhaler reminders improve adherence with controller treatment in primary care patients with asthma. J Allergy Clin Immunol 2014. pii: S0091-6749(14)00802-1.
37. Tran N, Coffman JM, Sumino K, Cabana MD. Patient reminder systems and asthma medication adherence: a systematic review. J Asthma 2014; 51:536-543.
38. Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc 2011; 86:304-314.
39. Gordon K, Smith F, Dhillon S. Effective chronic disease management: patients' perspectives on medication-related problems. Patient Educ Couns 2007; 65:407-415.
40. Braido F, Baiardini I, Menoni S, et al. Asthma management failure: a flaw in physicians' behavior or in patients' knowledge? J Asthma 2011; 48:266-274.